These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37952827)

  • 1. Inhibition of Sema4D attenuates pressure overload-induced pathological myocardial hypertrophy via the MAPK/NF-κB/NLRP3 pathways.
    Wu B; Xu C; Xu C; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Xia Z; Liu X
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166944. PubMed ID: 37952827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
    Higashikuni Y; Liu W; Numata G; Tanaka K; Fukuda D; Tanaka Y; Hirata Y; Imamura T; Takimoto E; Komuro I; Sata M
    Circulation; 2023 Jan; 147(4):338-355. PubMed ID: 36440584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
    Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S
    Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway.
    Ren B; Feng J; Yang N; Guo Y; Chen C; Qin Q
    Int Immunopharmacol; 2021 Sep; 98():107841. PubMed ID: 34153662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
    Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
    Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
    Zhao M; Zhang J; Xu Y; Liu J; Ye J; Wang Z; Ye D; Feng Y; Xu S; Pan W; Wang M; Wan J
    Int Immunopharmacol; 2021 Oct; 99():108046. PubMed ID: 34435581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy.
    Zou Y; Zhang M; Wu Q; Zhao N; Chen M; Yang C; Du Y; Han B
    Elife; 2022 Jun; 11():. PubMed ID: 35731090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaempferol-3-O-rutinoside exerts cardioprotective effects through NF-κB/NLRP3/Caspase-1 pathway in ventricular remodeling after acute myocardial infarction.
    Hua F; Li JY; Zhang M; Zhou P; Wang L; Ling TJ; Bao GH
    J Food Biochem; 2022 Oct; 46(10):e14305. PubMed ID: 35758877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
    Zhou H; Li N; Yuan Y; Jin YG; Wu Q; Yan L; Bian ZY; Deng W; Shen DF; Li H; Tang QZ
    J Mol Med (Berl); 2020 May; 98(5):691-705. PubMed ID: 32280997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
    Lei Q; Yi T; Chen C
    Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica nanoparticles induce pyroptosis and cardiac hypertrophy via ROS/NLRP3/Caspase-1 pathway.
    Wang F; Liang Q; Ma Y; Sun M; Li T; Lin L; Sun Z; Duan J
    Free Radic Biol Med; 2022 Mar; 182():171-181. PubMed ID: 35219847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSDMD-mediated pyroptosis promotes cardiac remodeling in pressure overload.
    You J; Li X; Dai F; Liu J; Zhang Q; Guo W
    Clin Exp Hypertens; 2023 Dec; 45(1):2189138. PubMed ID: 36906959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT5 up-regulation improves myocardial hypertrophy by mediating E2F-1/NF-κB/NLRP3 pathway.
    Zhang L; Wang H; Li W
    Prev Med; 2023 Jul; 172():107553. PubMed ID: 37217036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
    Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
    Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
    Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
    Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling.
    Xiong X; Liu Y; Mei Y; Peng J; Wang Z; Kong B; Zhong P; Xiong L; Quan D; Li Q; Wang G; Huang H
    Sci Rep; 2017 Feb; 7():41857. PubMed ID: 28165494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction.
    Chen F; Chen ZQ; Zhong GL; Zhu JJ
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1938-1947. PubMed ID: 34034564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.